Table 1 Patients in the LNESG1 study
No of patients | ||
|---|---|---|
Enrolled | 905 | |
Excluded | 215 | |
Inadequate MYCN gene assay | 95 | |
Staging errors | 47 | |
Wrong diagnosis | 28 | |
Undefined histology | 9 | |
Previous treatment | 13 | |
Parental refusal | 5 | |
Other reasons | 18 | |
Non-metastatic neuroblastoma | 690 | |
Ineligible for the study | 263 | |
Stage 3 | 192 | |
Ganglioneuroma | 71 | |
Eligible for the study | 427 | |
Study 1 | 295 | |
Without MYCNA | 288 | |
With MYCNA | 7 | |
Study 2 | 132 | |
Without MYCNA | 123 | |
With MYCNA | 9 |
